Gao B, Jaffe H, Kunos G
Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298, USA.
Mol Cell Biochem. 1998 Jan;178(1-2):187-96. doi: 10.1023/a:1006843514666.
Two polypeptides with molecular masses of 34 and 30 kDa were copurified from rat liver during DNA affinity purification of a sequence-specific transcription factor binding to the footprint II sequence within the P2 promoter of the rat alpha1B adrenergic receptor (alpha1B AR) gene, and were identified by microsequencing their endoproteinase Lys-C-derived peptides as histone H1d and histone H1c, respectively. Histone H1 was previously reported to bind to the nuclear factor 1 (NF1) recognition sequence, although the specificity of this binding has been controversial. Here, DNA mobility shift and supershift assays, DNase I footprinting and mutational analyses indicated that the binding of histone H1 to the NF1 sites located within footprint II of the alpha1B AR gene P2 promoter is nonspecific. Transient cotransfections into Hep3B cells of histone H1d cDNA with CAT constructs containing promoter regions of different genes resulted in generalized and non-specific suppression of CAT activity. The histone H1d-mediated repression of the activities of the alpha1B AR gene P2/CAT or beta2 AR gene P(-186/1307)/CAT constructs was reversed by the cotransfection of a cDNA encoding the sequence-specific transcription factor NF1/X, and the fold increase in CAT activities was similar to that obtained in the absence of histone H1d. These results suggest that sequence-specific transcription factors counteract the histone H1-mediated transcriptional repression in vivo by a true activation, which is different from the in vitro antirepression in histone H1-repressed chromatin templates (Laybourn and Kadonaga, (1991) Science 254: 238-245).
在对大鼠α1B肾上腺素能受体(α1B AR)基因P2启动子内足迹II序列具有序列特异性的转录因子进行DNA亲和纯化过程中,从大鼠肝脏中共同纯化出了分子量分别为34 kDa和30 kDa的两种多肽,通过对内肽酶Lys-C酶解产生的肽段进行微量测序,分别鉴定为组蛋白H1d和组蛋白H1c。此前有报道称组蛋白H1可与核因子1(NF1)识别序列结合,但其结合特异性一直存在争议。在此,DNA迁移率变动和超迁移分析、DNase I足迹分析及突变分析表明,组蛋白H1与α1B AR基因P2启动子足迹II内的NF1位点结合是非特异性的。将组蛋白H1d cDNA与含有不同基因启动子区域的CAT构建体瞬时共转染到Hep3B细胞中,导致CAT活性普遍且非特异性地受到抑制。编码序列特异性转录因子NF1/X的cDNA共转染可逆转组蛋白H1d介导的α1B AR基因P2/CAT或β2 AR基因P(-186/1307)/CAT构建体活性的抑制,CAT活性的增加倍数与无组蛋白H1d时相似。这些结果表明,序列特异性转录因子在体内通过真正的激活作用抵消组蛋白H1介导的转录抑制,这与组蛋白H1抑制的染色质模板中的体外抗抑制作用不同(Laybourn和Kadonaga,(1991年)《科学》254:238 - 245)。